1
|
Noro J, Vilaça-Faria H, Reis RL, Pirraco RP. Extracellular matrix-derived materials for tissue engineering and regenerative medicine: A journey from isolation to characterization and application. Bioact Mater 2024; 34:494-519. [PMID: 38298755 PMCID: PMC10827697 DOI: 10.1016/j.bioactmat.2024.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 12/19/2023] [Accepted: 01/03/2024] [Indexed: 02/02/2024] Open
Abstract
Biomaterial choice is an essential step during the development tissue engineering and regenerative medicine (TERM) applications. The selected biomaterial must present properties allowing the physiological-like recapitulation of several processes that lead to the reestablishment of homeostatic tissue or organ function. Biomaterials derived from the extracellular matrix (ECM) present many such properties and their use in the field has been steadily increasing. Considering this growing importance, it becomes imperative to provide a comprehensive overview of ECM biomaterials, encompassing their sourcing, processing, and integration into TERM applications. This review compiles the main strategies used to isolate and process ECM-derived biomaterials as well as different techniques used for its characterization, namely biochemical and chemical, physical, morphological, and biological. Lastly, some of their applications in the TERM field are explored and discussed.
Collapse
Affiliation(s)
- Jennifer Noro
- 3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017, Barco, Guimarães, Portugal
- ICVS/3B's – PT Government Associate Laboratory, Braga, Guimarães, Portugal
| | - Helena Vilaça-Faria
- 3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017, Barco, Guimarães, Portugal
- ICVS/3B's – PT Government Associate Laboratory, Braga, Guimarães, Portugal
| | - Rui L. Reis
- 3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017, Barco, Guimarães, Portugal
- ICVS/3B's – PT Government Associate Laboratory, Braga, Guimarães, Portugal
| | - Rogério P. Pirraco
- 3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017, Barco, Guimarães, Portugal
- ICVS/3B's – PT Government Associate Laboratory, Braga, Guimarães, Portugal
| |
Collapse
|
2
|
O'Connor CE, Neufeld A, Fortin CL, Johansson F, Mene J, Saxton SH, Simmonds SP, Kopyeva I, Gregorio NE, DeForest CA, Witten DM, Stevens KR. Highly Parallel Tissue Grafting for Combinatorial In Vivo Screening. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.03.16.533029. [PMID: 36993278 PMCID: PMC10055160 DOI: 10.1101/2023.03.16.533029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/19/2023]
Abstract
Material- and cell-based technologies such as engineered tissues hold great promise as human therapies. Yet, the development of many of these technologies becomes stalled at the stage of pre-clinical animal studies due to the tedious and low-throughput nature of in vivo implantation experiments. We introduce a 'plug and play' in vivo screening array platform called Highly Parallel Tissue Grafting (HPTG). HPTG enables parallelized in vivo screening of 43 three-dimensional microtissues within a single 3D printed device. Using HPTG, we screen microtissue formations with varying cellular and material components and identify formulations that support vascular self-assembly, integration and tissue function. Our studies highlight the importance of combinatorial studies that vary cellular and material formulation variables concomitantly, by revealing that inclusion of stromal cells can "rescue" vascular self-assembly in manner that is material-dependent. HPTG provides a route for accelerating pre-clinical progress for diverse medical applications including tissue therapy, cancer biomedicine, and regenerative medicine.
Collapse
|
3
|
Decarli MC, de Castro MV, Nogueira JA, Nagahara MHT, Westin CB, de Oliveira ALR, Silva JVL, Moroni L, Mota C, Moraes ÂM. Development of a device useful to reproducibly produce large quantities of viable and uniform stem cell spheroids with controlled diameters. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2022; 135:112685. [DOI: 10.1016/j.msec.2022.112685] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Revised: 12/20/2021] [Accepted: 01/22/2022] [Indexed: 01/08/2023]
|
4
|
Soheilmoghaddam F, Rumble M, Cooper-White J. High-Throughput Routes to Biomaterials Discovery. Chem Rev 2021; 121:10792-10864. [PMID: 34213880 DOI: 10.1021/acs.chemrev.0c01026] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Many existing clinical treatments are limited in their ability to completely restore decreased or lost tissue and organ function, an unenviable situation only further exacerbated by a globally aging population. As a result, the demand for new medical interventions has increased substantially over the past 20 years, with the burgeoning fields of gene therapy, tissue engineering, and regenerative medicine showing promise to offer solutions for full repair or replacement of damaged or aging tissues. Success in these fields, however, inherently relies on biomaterials that are engendered with the ability to provide the necessary biological cues mimicking native extracellular matrixes that support cell fate. Accelerating the development of such "directive" biomaterials requires a shift in current design practices toward those that enable rapid synthesis and characterization of polymeric materials and the coupling of these processes with techniques that enable similarly rapid quantification and optimization of the interactions between these new material systems and target cells and tissues. This manuscript reviews recent advances in combinatorial and high-throughput (HT) technologies applied to polymeric biomaterial synthesis, fabrication, and chemical, physical, and biological screening with targeted end-point applications in the fields of gene therapy, tissue engineering, and regenerative medicine. Limitations of, and future opportunities for, the further application of these research tools and methodologies are also discussed.
Collapse
Affiliation(s)
- Farhad Soheilmoghaddam
- Tissue Engineering and Microfluidics Laboratory (TEaM), Australian Institute for Bioengineering and Nanotechnology (AIBN), University Of Queensland, St. Lucia, Queensland, Australia 4072.,School of Chemical Engineering, University Of Queensland, St. Lucia, Queensland, Australia 4072
| | - Madeleine Rumble
- Tissue Engineering and Microfluidics Laboratory (TEaM), Australian Institute for Bioengineering and Nanotechnology (AIBN), University Of Queensland, St. Lucia, Queensland, Australia 4072.,School of Chemical Engineering, University Of Queensland, St. Lucia, Queensland, Australia 4072
| | - Justin Cooper-White
- Tissue Engineering and Microfluidics Laboratory (TEaM), Australian Institute for Bioengineering and Nanotechnology (AIBN), University Of Queensland, St. Lucia, Queensland, Australia 4072.,School of Chemical Engineering, University Of Queensland, St. Lucia, Queensland, Australia 4072
| |
Collapse
|
5
|
Guttenplan APM, Tahmasebi Birgani Z, Giselbrecht S, Truckenmüller RK, Habibović P. Chips for Biomaterials and Biomaterials for Chips: Recent Advances at the Interface between Microfabrication and Biomaterials Research. Adv Healthc Mater 2021; 10:e2100371. [PMID: 34033239 DOI: 10.1002/adhm.202100371] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Revised: 05/08/2021] [Indexed: 12/24/2022]
Abstract
In recent years, the use of microfabrication techniques has allowed biomaterials studies which were originally carried out at larger length scales to be miniaturized as so-called "on-chip" experiments. These miniaturized experiments have a range of advantages which have led to an increase in their popularity. A range of biomaterial shapes and compositions are synthesized or manufactured on chip. Moreover, chips are developed to investigate specific aspects of interactions between biomaterials and biological systems. Finally, biomaterials are used in microfabricated devices to replicate the physiological microenvironment in studies using so-called "organ-on-chip," "tissue-on-chip" or "disease-on-chip" models, which can reduce the use of animal models with their inherent high cost and ethical issues, and due to the possible use of human cells can increase the translation of research from lab to clinic. This review gives an overview of recent developments at the interface between microfabrication and biomaterials science, and indicates potential future directions that the field may take. In particular, a trend toward increased scale and automation is apparent, allowing both industrial production of micron-scale biomaterials and high-throughput screening of the interaction of diverse materials libraries with cells and bioengineered tissues and organs.
Collapse
Affiliation(s)
- Alexander P. M. Guttenplan
- Department of Instructive Biomaterials Engineering MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
| | - Zeinab Tahmasebi Birgani
- Department of Instructive Biomaterials Engineering MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
| | - Stefan Giselbrecht
- Department of Instructive Biomaterials Engineering MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
| | - Roman K. Truckenmüller
- Department of Instructive Biomaterials Engineering MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
| | - Pamela Habibović
- Department of Instructive Biomaterials Engineering MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
| |
Collapse
|
6
|
Decarli MC, do Amaral RLF, Dos Santos DP, Tofani LB, Katayama E, Rezende RA, Silva JVLD, Swiech K, Suazo CAT, Mota C, Moroni L, Moraes ÂM. Cell spheroids as a versatile research platform: formation mechanisms, high throughput production, characterization and applications. Biofabrication 2021; 13. [PMID: 33592595 DOI: 10.1088/1758-5090/abe6f2] [Citation(s) in RCA: 49] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2020] [Accepted: 02/16/2021] [Indexed: 11/12/2022]
Abstract
Three-dimensional cell culture has tremendous advantages to closely mimic the in vivo architecture and microenvironment of healthy tissue and organs, as well as of solid tumors. Spheroids are currently the most attractive 3D model to produce uniform reproducible cell structures as well as a potential basis for engineering large tissues and complex organs. In this review we discuss, from an engineering perspective, processes to obtain uniform 3D cell spheroids, comparing dynamic and static cultures and considering aspects such as mass transfer and shear stress. In addition, computational and mathematical modelling of complex cell spheroid systems are discussed. The non-cell-adhesive hydrogel-based method and dynamic cell culture in bioreactors are focused in detail and the myriad of developed spheroid characterization techniques is presented. The main bottlenecks and weaknesses are discussed, especially regarding the analysis of morphological parameters, cell quantification and viability, gene expression profiles, metabolic behavior and high-content analysis. Finally, a vast set of applications of spheroids as tools for in vitro study model systems is examined, including drug screening, tissue formation, pathologies development, tissue engineering and biofabrication, 3D bioprinting and microfluidics, together with their use in high-throughput platforms.
Collapse
Affiliation(s)
- Monize Caiado Decarli
- School of Chemical Engineering/Department of Engineering of Materials and of Bioprocesses, University of Campinas, Av. Albert Einstein, 500 - Bloco A - Cidade Universitária Zeferino Vaz, Cidade Universitária Zeferino Vaz, Campinas, SP, 13083-852, BRAZIL
| | - Robson Luis Ferraz do Amaral
- School of Pharmaceutical Sciences of Ribeirão Preto/Department of Pharmaceutical Sciences, University of São Paulo, Avenida do Café, no number, Ribeirão Preto, SP, 14040-903, BRAZIL
| | - Diogo Peres Dos Santos
- Departament of Chemical Engineering, Federal University of São Carlos, Rod. Washington Luiz (SP-310), km 235, São Carlos, SP, 13565-905, BRAZIL
| | - Larissa Bueno Tofani
- School of Pharmaceutical Sciences of Ribeirão Preto/Department of Pharmaceutical Sciences, University of São Paulo, Avenida do Café, no number, Ribeirão Preto, SP, 14040-903, BRAZIL
| | - Eric Katayama
- Departament of Chemical Engineering, Federal University of São Carlos, Rod. Washington Luiz (SP-310), km 235, São Carlos, SP, 13565-905, BRAZIL
| | - Rodrigo Alvarenga Rezende
- Centro de Tecnologia da Informacao Renato Archer, Rod. Dom Pedro I (SP-65), km 143,6 - Amarais, Campinas, SP, 13069-901, BRAZIL
| | - Jorge Vicente Lopes da Silva
- Centro de Tecnologia da Informacao Renato Archer, Rod. Dom Pedro I (SP-65), km 143,6 - Amarais, Campinas, SP, 13069-901, BRAZIL
| | - Kamilla Swiech
- University of Sao Paulo, School of Pharmaceutical Sciences of Ribeirão Preto/Department of Pharmaceutical Sciences, Ribeirao Preto, SP, 14040-903, BRAZIL
| | - Cláudio Alberto Torres Suazo
- Department of Chemical Engineering, Federal University of São Carlos, Rod. Washington Luiz (SP-310), km 235, São Carlos, SP, 13565-905, BRAZIL
| | - Carlos Mota
- Department of Complex Tissue Regeneration (CTR), University of Maastricht , Universiteitssingel, 40, office 3.541A, Maastricht, 6229 ER, NETHERLANDS
| | - Lorenzo Moroni
- Complex Tissue Regeneration, Maastricht University, Universiteitsingel, 40, Maastricht, 6229ER, NETHERLANDS
| | - Ângela Maria Moraes
- School of Chemical Engineering/Department of Engineering of Materials and of Bioprocesses, University of Campinas, Av. Albert Einstein, 500 - Bloco A - Cidade Universitária Zeferino Vaz, Campinas, SP, 13083-852, BRAZIL
| |
Collapse
|
7
|
Słynarski K, de Jong WC, Snow M, Hendriks JAA, Wilson CE, Verdonk P. Single-Stage Autologous Chondrocyte-Based Treatment for the Repair of Knee Cartilage Lesions: Two-Year Follow-up of a Prospective Single-Arm Multicenter Study. Am J Sports Med 2020; 48:1327-1337. [PMID: 32267734 DOI: 10.1177/0363546520912444] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
BACKGROUND There is an unmet need for a single-stage cartilage repair treatment that is cost-effective and chondrocyte-based. PURPOSE To evaluate the safety and preliminary efficacy of autologous freshly isolated primary chondrocytes and bone marrow mononucleated cells (MNCs) seeded into a PolyActive scaffold in patients with symptomatic cartilage lesions of the knee. STUDY DESIGN Case series; Level of evidence, 4. METHODS A total of 40 patients with symptomatic knee cartilage lesions were treated with freshly isolated autologous chondrocytes combined with bone marrow MNCs delivered in a biodegradable load-bearing scaffold. The treatment requires only 1 surgical intervention and is potentially a cost-effective alternative to autologous chondrocyte implantation. The primary chondrocytes and bone marrow MNCs were isolated, washed, counted, mixed, and seeded into a load-bearing scaffold in the operating room. Patients were followed up at 3, 6, 12, 18, and 24 months. Primary endpoints were treatment-related adverse events up to 3 months, adverse implant effects between 3 and 24 months, and the implant success rate at 3 months as measured by lesion filling. RESULTS Successful lesion filling (≥67% on magnetic resonance imaging) was found in 40 patients at 3 months and in 32 of the 32 patients analyzed at 24 months. Significant improvement over baseline was found for visual analog scale for pain from 3 months onward; Knee injury and Osteoarthritis Outcome Score (KOOS)-Pain and KOOS-Activities of Daily Living from 6 months onward; for KOOS-Symptoms and Stiffness, KOOS-Quality of Life and International Knee Documentation Committee from 12 months onward; and for KOOS-Sport and Recreation from 18 months onward. Hyaline-like repair tissue was found in 22 of 31 patients available for biopsy. Arthralgia and joint effusion were the most common adverse events. Scaffold delamination and adhesions led to removal of the implant in 2 patients. CONCLUSION The treatment of knee cartilage lesions with autologous primary chondrocytes and bone marrow MNCs, both isolated and seeded into a load-bearing PolyActive scaffold within a single surgical intervention, is safe and clinically effective. Good lesion fill and sustained clinically important and statistically significant improvement in all patient-reported outcome scores were found throughout the 24-month study. Hyaline-like cartilage was observed on biopsy specimen in at least 22 of the 40 patients. REGISTRATION NCT01041885 (ClinicalTrials.gov identifier).
Collapse
Affiliation(s)
| | - Willem Cornelis de Jong
- Cartilage Repair Systems, LLC, New York, New York, USA.,CellCoTec BV, Bilthoven, the Netherlands
| | - Martyn Snow
- The Royal Orthopaedic Hospital, Birmingham, UK
| | | | - Clayton Ellis Wilson
- Cartilage Repair Systems, LLC, New York, New York, USA.,CellCoTec BV, Bilthoven, the Netherlands
| | - Peter Verdonk
- Antwerp Orthopedic Center, AZ Monica, Antwerp, Belgium.,Antwerp University Hospital, Antwerp, Belgium
| |
Collapse
|
8
|
Al-Maawi S, Mota C, Kubesch A, James Kirkpatrick C, Moroni L, Ghanaati S. Multiwell three-dimensional systems enable in vivo screening of immune reactions to biomaterials: a new strategy toward translational biomaterial research. JOURNAL OF MATERIALS SCIENCE. MATERIALS IN MEDICINE 2019; 30:61. [PMID: 31127377 DOI: 10.1007/s10856-019-6263-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2018] [Accepted: 05/06/2019] [Indexed: 06/09/2023]
Abstract
In vivo experiments are accompanied by ethical issues, including sacrificing a large number of animals as well as large costs. A new in vivo 3D screening system was developed to reduce the number of required animals without compromising the results. The present pilot study examined a multiwell array system in combination with three different collagen-based biomaterials (A, B and C) using subcutaneous implantation for 10 days and histological and histomorphometrical evaluations. The tissue reaction towards the device itself was dominated by mononuclear cells. However, three independent biomaterial-specific tissue reactions were observed in three chambers. The results showed a mononuclear cell-based tissue reaction in one chamber (A) and foreign body reaction by multinucleated giant cells in the other two chambers (B and C). Statistical analysis showed a significantly higher number of multinucleated giant cells in cases B and C than in case A (A vs. B; ***P < 0.001), (A vs. C; P < 0.01). These outcomes were comparable to previously published observations with conventional biomaterial implantation. The present data lead to the conclusion that this 3D screening system could be an alternative tool to enhance the effectiveness of in vivo experiments, thus offering a more economic strategy to screen biomaterial-related cellular reactions, while saving animals, without influencing the final outcome.
Collapse
Affiliation(s)
- Sarah Al-Maawi
- FORM-lab, Department for Oral, Cranio-Maxillofacial and Facial Plastic Surgery, Medical Center of the Goethe University Frankfurt, Frankfurt, Germany
| | - Carlos Mota
- Maastricht University, MERLN Institute for Technology-Inspired Regenerative Medicine, Complex Tissue Regeneration Department, Maastricht, The Netherlands
| | - Alica Kubesch
- FORM-lab, Department for Oral, Cranio-Maxillofacial and Facial Plastic Surgery, Medical Center of the Goethe University Frankfurt, Frankfurt, Germany
| | - C James Kirkpatrick
- FORM-lab, Department for Oral, Cranio-Maxillofacial and Facial Plastic Surgery, Medical Center of the Goethe University Frankfurt, Frankfurt, Germany
| | - Lorenzo Moroni
- Maastricht University, MERLN Institute for Technology-Inspired Regenerative Medicine, Complex Tissue Regeneration Department, Maastricht, The Netherlands
| | - Shahram Ghanaati
- FORM-lab, Department for Oral, Cranio-Maxillofacial and Facial Plastic Surgery, Medical Center of the Goethe University Frankfurt, Frankfurt, Germany.
| |
Collapse
|
9
|
Abstract
INTRODUCTION Cartilage tissue engineering has rapidly developed in recent decades, exhibiting promising potential to regenerate and repair cartilage. However, the origin of a large amount of a suitable seed cell source is the major bottleneck for the further clinical application of cartilage tissue engineering. The use of a monoculture of passaged chondrocytes or mesenchymal stem cells results in undesired outcomes, such as fibrocartilage formation and hypertrophy. In the last two decades, co-cultures of chondrocytes and a variety of mesenchymal stem cells have been intensively investigated in vitro and in vivo, shedding light on the perspective of co-culture in cartilage tissue engineering. AREAS COVERED We summarize the recent literature on the application of heterologous cell co-culture systems in cartilage tissue engineering and compare the differences between direct and indirect co-culture systems as well as discuss the underlying mechanisms. EXPERT OPINION Co-culture system is proven to address many issues encountered by monocultures in cartilage tissue engineering, including reducing the number of chondrocytes needed and alleviating the dedifferentiation of chondrocytes. With the further development and knowledge of biomaterials, cartilage tissue engineering that combines the co-culture system and advanced biomaterials is expected to solve the difficult problem regarding the regeneration of functional cartilage.
Collapse
Affiliation(s)
- Jianyu Zou
- a Department of Joint Surgery , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China.,b Guangdong key laboratory of orthopaedic technology and implant materials , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China
| | - Bo Bai
- a Department of Joint Surgery , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China.,b Guangdong key laboratory of orthopaedic technology and implant materials , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China
| | - Yongchang Yao
- a Department of Joint Surgery , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China.,b Guangdong key laboratory of orthopaedic technology and implant materials , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China
| |
Collapse
|
10
|
Duan W, Chen C, Haque M, Hayes D, Lopez MJ. Polymer-mineral scaffold augments in vivo equine multipotent stromal cell osteogenesis. Stem Cell Res Ther 2018. [PMID: 29523214 PMCID: PMC5845133 DOI: 10.1186/s13287-018-0790-8] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Background Use of bioscaffolds to direct osteogenic differentiation of adult multipotent stromal cells (MSCs) without exogenous proteins is a contemporary approach to bone regeneration. Identification of in vivo osteogenic contributions of exogenous MSCs on bioscaffolds after long-term implantation is vital to understanding cell persistence and effect duration. Methods This study was designed to quantify in vivo equine MSC osteogenesis on synthetic polymer scaffolds with distinct mineral combinations 9 weeks after implantation in a murine model. Cryopreserved, passage (P)1, equine bone marrow-derived MSCs (BMSC) and adipose tissue-derived MSCs (ASC) were culture expanded to P3 and immunophenotyped with flow cytometry. They were then loaded by spinner flask on to scaffolds composed of tricalcium phosphate (TCP)/hydroxyapatite (HA) (40:60; HT), polyethylene glycol (PEG)/poly-l-lactic acid (PLLA) (60:40; GA), or PEG/PLLA/TCP/HA (36:24:24:16; GT). Scaffolds with and without cells were maintained in static culture for up to 21 days or implanted subcutaneously in athymic mice that were radiographed every 3 weeks up to 9 weeks. In vitro cell viability and proliferation were determined. Explant composition (double-stranded (ds)DNA, collagen, sulfated glycosaminoglycan (sGAG), protein), equine and murine osteogenic target gene expression, microcomputed tomography (μCT) mineralization, and light microscopic structure were assessed. Results The ASC and BMSC number increased significantly in HT constructs between 7 and 21 days of culture, and BMSCs increased similarly in GT constructs. Radiographic opacity increased with time in GT-BMSC constructs. Extracellular matrix (ECM) components and dsDNA increased significantly in GT compared to HT constructs. Equine and murine osteogenic gene expression was highest in BMSC constructs with mineral-containing scaffolds. The HT constructs with either cell type had the highest mineral deposition based on μCT. Regardless of composition, scaffolds with cells had more ECM than those without, and osteoid was apparent in all BMSC constructs. Conclusions In this study, both exogenous and host MSCs appear to contribute to in vivo osteogenesis. Addition of mineral to polymer scaffolds enhances equine MSC osteogenesis over polymer alone, but pure mineral scaffold provides superior osteogenic support. These results emphasize the need for bioscaffolds that provide customized osteogenic direction of both exo- and endogenous MSCs for the best regenerative potential.
Collapse
Affiliation(s)
- Wei Duan
- Laboratory for Equine and Comparative Orthopedic Research, Louisiana State University, Baton Rouge, LA, USA
| | - Cong Chen
- Department of Biomedical Engineering, Pennsylvania State University, University Park, PA, USA
| | - Masudul Haque
- Laboratory for Equine and Comparative Orthopedic Research, Louisiana State University, Baton Rouge, LA, USA
| | - Daniel Hayes
- Department of Biomedical Engineering, Pennsylvania State University, University Park, PA, USA
| | - Mandi J Lopez
- Laboratory for Equine and Comparative Orthopedic Research, Louisiana State University, Baton Rouge, LA, USA.
| |
Collapse
|
11
|
Lopa S, Mondadori C, Mainardi VL, Talò G, Costantini M, Candrian C, Święszkowski W, Moretti M. Translational Application of Microfluidics and Bioprinting for Stem Cell-Based Cartilage Repair. Stem Cells Int 2018; 2018:6594841. [PMID: 29535776 PMCID: PMC5838503 DOI: 10.1155/2018/6594841] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2017] [Revised: 11/06/2017] [Accepted: 12/05/2017] [Indexed: 01/09/2023] Open
Abstract
Cartilage defects can impair the most elementary daily activities and, if not properly treated, can lead to the complete loss of articular function. The limitations of standard treatments for cartilage repair have triggered the development of stem cell-based therapies. In this scenario, the development of efficient cell differentiation protocols and the design of proper biomaterial-based supports to deliver cells to the injury site need to be addressed through basic and applied research to fully exploit the potential of stem cells. Here, we discuss the use of microfluidics and bioprinting approaches for the translation of stem cell-based therapy for cartilage repair in clinics. In particular, we will focus on the optimization of hydrogel-based materials to mimic the articular cartilage triggered by their use as bioinks in 3D bioprinting applications, on the screening of biochemical and biophysical factors through microfluidic devices to enhance stem cell chondrogenesis, and on the use of microfluidic technology to generate implantable constructs with a complex geometry. Finally, we will describe some new bioprinting applications that pave the way to the clinical use of stem cell-based therapies, such as scaffold-free bioprinting and the development of a 3D handheld device for the in situ repair of cartilage defects.
Collapse
Affiliation(s)
- Silvia Lopa
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Milan, Italy
| | - Carlotta Mondadori
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Milan, Italy
- Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy
| | - Valerio Luca Mainardi
- Regenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland
- Laboratory of Biological Structures Mechanics-Chemistry, Material and Chemical Engineering Department “Giulio Natta”, Politecnico di Milano, Milan, Italy
| | - Giuseppe Talò
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Milan, Italy
| | - Marco Costantini
- Department of Chemistry, Sapienza University of Rome, Rome, Italy
| | - Christian Candrian
- Regenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland
- Unità di Traumatologia e Ortopedia-ORL, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland
| | - Wojciech Święszkowski
- Faculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland
| | - Matteo Moretti
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Milan, Italy
- Regenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland
- Swiss Institute for Regenerative Medicine, Lugano, Switzerland
| |
Collapse
|
12
|
Barui A, Chowdhury F, Pandit A, Datta P. Rerouting mesenchymal stem cell trajectory towards epithelial lineage by engineering cellular niche. Biomaterials 2018; 156:28-44. [DOI: 10.1016/j.biomaterials.2017.11.036] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Revised: 10/22/2017] [Accepted: 11/21/2017] [Indexed: 02/06/2023]
|
13
|
An expandable embryonic stem cell-derived Purkinje neuron progenitor population that exhibits in vivo maturation in the adult mouse cerebellum. Sci Rep 2017; 7:8863. [PMID: 28821816 PMCID: PMC5562837 DOI: 10.1038/s41598-017-09348-1] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2016] [Accepted: 07/26/2017] [Indexed: 11/08/2022] Open
Abstract
The directed differentiation of patient-derived induced pluripotent stem cells into cell-type specific neurons has inspired the development of therapeutic discovery for neurodegenerative diseases. Many forms of ataxia result from degeneration of cerebellar Purkinje cells, but thus far it has not been possible to efficiently generate Purkinje neuron (PN) progenitors from human or mouse pluripotent stem cells, let alone to develop a methodology for in vivo transplantation in the adult cerebellum. Here, we present a protocol to obtain an expandable population of cerebellar neuron progenitors from mouse embryonic stem cells. Our protocol is characterized by applying factors that promote proliferation of cerebellar progenitors. Cerebellar progenitors isolated in culture from cell aggregates contained a stable subpopulation of PN progenitors that could be expanded for up to 6 passages. When transplanted into the adult cerebellum of either wild-type mice or a strain lacking Purkinje cells (L7cre-ERCC1 knockout), GFP-labeled progenitors differentiated in vivo to establish a population of calbindin-positive cells in the molecular layer with dendritic trees typical of mature PNs. We conclude that this protocol may be useful for the generation and maturation of PNs, highlighting the potential for development of a regenerative medicine approach to the treatment of cerebellar neurodegenerative diseases.
Collapse
|
14
|
Dollinger C, Ndreu-Halili A, Uka A, Singh S, Sadam H, Neuman T, Rabineau M, Lavalle P, Dokmeci MR, Khademhosseini A, Ghaemmaghami AM, Vrana NE. Controlling Incoming Macrophages to Implants: Responsiveness of Macrophages to Gelatin Micropatterns under M1/M2 Phenotype Defining Biochemical Stimulations. ACTA ACUST UNITED AC 2017. [DOI: 10.1002/adbi.201700041] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
| | | | - Arban Uka
- Department of Computer Engineering; Epoka University; 1039 Tirana Albania
| | - Sonali Singh
- Faculty of Medicine; University of Nottingham; Nottingham NG7 2UH UK
| | | | | | - Morgane Rabineau
- Institut National de la Santé et de la Recherche Médicale; INSERM; UMR-S 1121 Strasbourg Cedex 67000 France
| | - Philippe Lavalle
- Institut National de la Santé et de la Recherche Médicale; INSERM; UMR-S 1121 Strasbourg Cedex 67000 France
- Faculté de Chirurgie Dentaire; Université de Strasbourg; 1 Place de l'Hôpital Strasbourg 67000 France
| | - Mehmet R. Dokmeci
- Center for Biomedical Engineering; Department of Medicine; Brigham and Women's Hospital; Harvard Medical School; Cambridge MA 02115 USA
- Harvard-MIT Division of Health Sciences and Technology; Massachusetts Institute of Technology; Cambridge MA 02319 USA
| | - Ali Khademhosseini
- Center for Biomedical Engineering; Department of Medicine; Brigham and Women's Hospital; Harvard Medical School; Cambridge MA 02115 USA
- Harvard-MIT Division of Health Sciences and Technology; Massachusetts Institute of Technology; Cambridge MA 02319 USA
- Wyss Institute for Biologically Inspired Engineering; Harvard Medical School; Boston MA 02155 USA
- Department of Maxillofacial Biomedical Engineering and Institute of Oral Biology; School of Dentistry; Kyung Hee University; Seoul 130-701 Republic of Korea
- Department of Physics; King Abdulaziz University; Jeddah 21569 Saudi Arabia
| | | | - Nihal E. Vrana
- Protip Medical; Fundamental Research Unit; 67000 Strasbourg France
| |
Collapse
|
15
|
Beijer NRM, Vasilevich AS, Pilavci B, Truckenmüller RK, Zhao Y, Singh S, Papenburg BJ, de Boer J. TopoWellPlate: A Well-Plate-Based Screening Platform to Study Cell-Surface Topography Interactions. ACTA ACUST UNITED AC 2017; 1:e1700002. [DOI: 10.1002/adbi.201700002] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2017] [Revised: 02/08/2017] [Indexed: 12/21/2022]
Affiliation(s)
- Nick R. M. Beijer
- Department of Cell Biology Inspired Tissue Engineering; MERLN Institute for Technology-Inspired Regenerative Medicine; Maastricht University; Universiteitssingel 40, Maastricht 6229 ER The Netherlands
| | - Aliaksei S. Vasilevich
- Department of Cell Biology Inspired Tissue Engineering; MERLN Institute for Technology-Inspired Regenerative Medicine; Maastricht University; Universiteitssingel 40, Maastricht 6229 ER The Netherlands
| | - Bayram Pilavci
- Department of Cell Biology Inspired Tissue Engineering; MERLN Institute for Technology-Inspired Regenerative Medicine; Maastricht University; Universiteitssingel 40, Maastricht 6229 ER The Netherlands
| | - Roman K. Truckenmüller
- Department of Complex Tissue Regeneration; MERLN Institute for Technology-Inspired Regenerative Medicine; Maastricht University; Universiteitssingel 40, Maastricht 6229 ER The Netherlands
| | - Yiping Zhao
- Materiomics BV; Oxfordlaan 70, Maastricht 6229 EV The Netherlands
| | - Shantanu Singh
- Imaging Platform; Broad institute of MIT and Harvard; 415 Main street, Cambridge MA 02142 USA
| | | | - Jan de Boer
- Department of Cell Biology Inspired Tissue Engineering; MERLN Institute for Technology-Inspired Regenerative Medicine; Maastricht University; Universiteitssingel 40, Maastricht 6229 ER The Netherlands
| |
Collapse
|
16
|
Spitters TWGM, Mota CMD, Uzoechi SC, Slowinska B, Martens DE, Moroni L, Karperien M. Glucose gradients influence zonal matrix deposition in 3D cartilage constructs. Tissue Eng Part A 2015; 20:3270-8. [PMID: 24903611 DOI: 10.1089/ten.tea.2014.0059] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Reproducing the native collagen structure and glycosaminoglycan (GAG) distribution in tissue-engineered cartilage constructs is still a challenge. Articular cartilage has a specific nutrient supply and mechanical environment due to its location and function in the body. Efforts to simulate this native environment have been reported through the use of bioreactor systems. However, few of these devices take into account the existence of gradients over cartilage as a consequence of the nutrient supply by diffusion. We hypothesized that culturing chondrocytes in an environment, in which gradients of nutrients can be mimicked, would induce zonal differentiation. Indeed, we show that glucose gradients facilitating a concentration distribution as low as physiological glucose levels enhanced a zonal chondrogenic capacity similar to the one found in native cartilage. Furthermore, we found that the glucose consumption rates of cultured chondrocytes were higher under physiological glucose concentrations and that GAG production rates were highest in 5 mM glucose. From these findings, we concluded that this condition is better suited for matrix deposition compared to 20 mM glucose standard used in a chondrocyte culture system. Reconsidering the culture conditions in cartilage tissue engineering strategies can lead to cartilaginous constructs that have better mechanical and structural properties, thus holding the potential of further enhancing integration with the host tissue.
Collapse
Affiliation(s)
- Tim W G M Spitters
- 1 Department of Developmental BioEngineering, MIRA Institute, University of Twente , Enschede, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
17
|
Higuera GA, Fernandes H, Spitters TWGM, van de Peppel J, Aufferman N, Truckenmueller R, Escalante M, Stoop R, van Leeuwen JP, de Boer J, Subramaniam V, Karperien M, van Blitterswijk C, van Boxtel A, Moroni L. Spatiotemporal proliferation of human stromal cells adjusts to nutrient availability and leads to stanniocalcin-1 expression in vitro and in vivo. Biomaterials 2015; 61:190-202. [PMID: 26004234 DOI: 10.1016/j.biomaterials.2015.05.017] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2015] [Revised: 05/05/2015] [Accepted: 05/14/2015] [Indexed: 01/08/2023]
Abstract
Cells and tissues are intrinsically adapted to molecular gradients and use them to maintain or change their activity. The effect of such gradients is particularly important for cell populations that have an intrinsic capacity to differentiate into multiple cell lineages, such as bone marrow derived mesenchymal stromal cells (MSCs). Our results showed that nutrient gradients prompt the spatiotemporal organization of MSCs in 3D culture. Cells adapted to their 3D environment without significant cell death or cell differentiation. Kinetics data and whole-genome gene expression analysis suggest that a low proliferation activity phenotype predominates in stromal cells cultured in 3D, likely due to increasing nutrient limitation. These differences implied that despite similar surface areas available for cell attachment, higher cell concentrations in 3D reduced MSCs proliferation, while activating hypoxia related-pathways. To further understand the in vivo effects of both proliferation and cell concentrations, we increased cell concentrations in small (1.8 μl) implantable wells. We found that MSCs accumulation and conditioning by nutrient competition in small volumes leads to an ideal threshold of cell-concentration for the induction of blood vessel formation, possibly signaled by the hypoxia-related stanniocalcin-1 gene.
Collapse
Affiliation(s)
- Gustavo A Higuera
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands.
| | - Hugo Fernandes
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Tim W G M Spitters
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Jeroen van de Peppel
- Erasmus Medical Center, Internal Medicine, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands
| | - Nils Aufferman
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Roman Truckenmueller
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Maryana Escalante
- Biophysical Engineering Group, Mesa(+) Institute for Nanotechnology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Reinout Stoop
- TNO, Metabolic Health Research, Zernikedreef 9, 2333 CK Leiden, The Netherlands
| | - Johannes P van Leeuwen
- Erasmus Medical Center, Internal Medicine, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands
| | - Jan de Boer
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Vinod Subramaniam
- Biophysical Engineering Group, Mesa(+) Institute for Nanotechnology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Marcel Karperien
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Clemens van Blitterswijk
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| | - Anton van Boxtel
- Systems and Control Group, Wageningen University, PO Box 17, 6700 AA Wageningen, The Netherlands
| | - Lorenzo Moroni
- Department of Tissue Regeneration, MIRA - Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands
| |
Collapse
|
18
|
Kim T, Folcher M, Charpin-El Hamri G, Fussenegger M. A synthetic cGMP-sensitive gene switch providing Viagra(®)-controlled gene expression in mammalian cells and mice. Metab Eng 2015; 29:169-179. [PMID: 25843350 DOI: 10.1016/j.ymben.2015.03.016] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2014] [Revised: 03/11/2015] [Accepted: 03/25/2015] [Indexed: 01/20/2023]
Abstract
Cyclic guanosine monophosphate (cGMP) is a universal second messenger that is synthesized from guanosine triphosphate (GTP) by guanylyl cyclases (GCs) and hydrolyzed into guanosine monophosphate (GMP) by phosphodiesterases (PDEs). Small-molecule drugs that induce high cGMP levels in specialized tissues by boosting GC activity or inhibiting PDE activity have become the predominant treatment strategy for a wide range of medical conditions, including congestive heart failure, pulmonary hypertension, atherosclerosis-based claudication and erectile dysfunction. By fusing the cGMP receptor protein (CRP) of Rhodospirillum centenum to the Herpes simplex-derived transactivation domain VP16, we created a novel synthetic mammalian cGMP-sensing transcription factor (GTA) that activates synthetic promoters (PGTA) containing newly identified GTA-specific operator sites in a concentration-dependent manner. In cell lines expressing endogenous natriuretic peptide receptor A (NPR-A) (HeLa), GTA/PGTA-driven transgene expression was induced by B-type natriuretic peptide (BNP; Nesiritide(®)) in a concentration-dependent manner, which activated NPR-A׳s intracellular GC domain and triggered a corresponding cGMP surge. Ectopic expression of NPR-A in NPR-A-negative cell lines (HEK-293T) produced high cGMP levels and mediated maximum GTA/PGTA-driven transgene expression, which was suppressed by co-expression of PDEs (PDE-3A, PDE-5A and PDE-9A) and was re-triggered by the corresponding PDE inhibitor drugs (Pletal(®), Perfan(®), Primacor(®) (PDE-3A), Viagra(®), Levitra(®), Cialis(®) (PDE-5A) and BAY73-6691 (PDE-9A)). Mice implanted with microencapsulated designer cells co-expressing the GTA/PGTA device with NPR-A and PDE-5A showed control of blood SEAP levels through administration of sildenafil (Viagra(®)). Designer cells engineered for PDE inhibitor-modulated transgene expression may provide a cell-based PDE-targeting drug discovery platform and enable drug-adjusted gene- and cell-based therapies.
Collapse
Affiliation(s)
- Taeuk Kim
- Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, CH-4058 Basel, Switzerland
| | - Marc Folcher
- Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, CH-4058 Basel, Switzerland
| | | | - Martin Fussenegger
- Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, CH-4058 Basel, Switzerland; Faculty of Science, University of Basel, Mattenstrasse 26, CH-4058 Basel, Switzerland.
| |
Collapse
|
19
|
Costa PF. Biofabricated constructs as tissue models: a short review. JOURNAL OF MATERIALS SCIENCE. MATERIALS IN MEDICINE 2015; 26:156. [PMID: 25779513 DOI: 10.1007/s10856-015-5502-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2014] [Accepted: 02/24/2015] [Indexed: 06/04/2023]
Abstract
Biofabrication is currently able to provide reliable models for studying the development of cells and tissues into multiple environments. As the complexity of biofabricated constructs is becoming increasingly higher their ability to closely mimic native tissues and organs is also increasing. Various biofabrication technologies currently allow to precisely build cell/tissue constructs at multiple dimension ranges with great accuracy. Such technologies are also able to assemble together multiple types of cells and/or materials and generate constructs closely mimicking various types of tissues. Furthermore, the high degree of automation involved in these technologies enables the study of large arrays of testing conditions within increasingly smaller and automated devices both in vitro and in vivo. Despite not yet being able to generate constructs similar to complex tissues and organs, biofabrication is rapidly evolving in that direction. One major hurdle to be overcome in order for such level of complex detail to be achieved is the ability to generate complex vascular structures within biofabricated constructs. This review describes several of the most relevant technologies and methodologies currently utilized within biofabrication and provides as well a brief overview of their current and future potential applications.
Collapse
Affiliation(s)
- Pedro F Costa
- Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Trogerstr. 30, 81675, Munich, Germany,
| |
Collapse
|
20
|
Lopa S, Piraino F, Kemp RJ, Di Caro C, Lovati AB, Di Giancamillo A, Moroni L, Peretti GM, Rasponi M, Moretti M. Fabrication of multi-well chips for spheroid cultures and implantable constructs through rapid prototyping techniques. Biotechnol Bioeng 2015; 112:1457-71. [PMID: 25678107 DOI: 10.1002/bit.25557] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2014] [Revised: 01/23/2015] [Accepted: 01/26/2015] [Indexed: 01/29/2023]
Abstract
Three-dimensional (3D) culture models are widely used in basic and translational research. In this study, to generate and culture multiple 3D cell spheroids, we exploited laser ablation and replica molding for the fabrication of polydimethylsiloxane (PDMS) multi-well chips, which were validated using articular chondrocytes (ACs). Multi-well ACs spheroids were comparable or superior to standard spheroids, as revealed by glycosaminoglycan and type-II collagen deposition. Moreover, the use of our multi-well chips significantly reduced the operation time for cell seeding and medium refresh. Exploiting a similar approach, we used clinical-grade fibrin to generate implantable multi-well constructs allowing for the precise distribution of multiple cell types. Multi-well fibrin constructs were seeded with ACs generating high cell density regions, as shown by histology and cell fluorescent staining. Multi-well constructs were compared to standard constructs with homogeneously distributed ACs. After 7 days in vitro, expression of SOX9, ACAN, COL2A1, and COMP was increased in both constructs, with multi-well constructs expressing significantly higher levels of chondrogenic genes than standard constructs. After 5 weeks in vivo, we found that despite a dramatic size reduction, the cell distribution pattern was maintained and glycosaminoglycan content per wet weight was significantly increased respect to pre-implantation samples. In conclusion, multi-well chips for the generation and culture of multiple cell spheroids can be fabricated by low-cost rapid prototyping techniques. Furthermore, these techniques can be used to generate implantable constructs with defined architecture and controlled cell distribution, allowing for in vitro and in vivo investigation of cell interactions in a 3D environment.
Collapse
Affiliation(s)
- Silvia Lopa
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Via R. Galeazzi 4, 20161, Milan, Italy
| | - Francesco Piraino
- Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, 20133, Italy
| | - Raymond J Kemp
- Tissue Regeneration Department, University of Twente, 7522 NB, Enschede, The Netherlands
| | - Clelia Di Caro
- Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, 20133, Italy
| | - Arianna B Lovati
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Via R. Galeazzi 4, 20161, Milan, Italy
| | | | - Lorenzo Moroni
- Tissue Regeneration Department, University of Twente, 7522 NB, Enschede, The Netherlands
- Department of Complex Tissue Regeneration, Maastricht University, 6200 MD, Maastricht, The Netherlands
| | - Giuseppe M Peretti
- IRCCS Galeazzi Orthopaedic Institute, Milan, 20161, Italy
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, 20161, Italy
| | - Marco Rasponi
- Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, 20133, Italy
| | - Matteo Moretti
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Via R. Galeazzi 4, 20161, Milan, Italy.
| |
Collapse
|
21
|
Chan TM, Lin HP, Lin SZ. In situ altering of the extracellular matrix to direct the programming of endogenous stem cells. Stem Cells 2015; 32:1989-90. [PMID: 24590489 DOI: 10.1002/stem.1693] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2013] [Accepted: 01/18/2014] [Indexed: 12/12/2022]
Affiliation(s)
- Tzu-Min Chan
- Center for Neuropsychiatry, China Medical University Hospital, Taichung, Taiwan, Republic of China; Everfront Biotech, Inc., New Taipei City, Taiwan, Republic of China
| | | | | |
Collapse
|
22
|
de Windt TS, Hendriks JAA, Zhao X, Vonk LA, Creemers LB, Dhert WJA, Randolph MA, Saris DBF. Concise review: unraveling stem cell cocultures in regenerative medicine: which cell interactions steer cartilage regeneration and how? Stem Cells Transl Med 2014. [PMID: 24763684 DOI: 10.5966/sctm.2013-020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Cartilage damage and osteoarthritis (OA) impose an important burden on society, leaving both young, active patients and older patients disabled and affecting quality of life. In particular, cartilage injury not only imparts acute loss of function but also predisposes to OA. The increase in knowledge of the consequences of these diseases and the exponential growth in research of regenerative medicine have given rise to different treatment types. Of these, cell-based treatments are increasingly applied because they have the potential to regenerate cartilage, treat symptoms, and ultimately prevent or delay OA. Although these approaches give promising results, they require a costly in vitro cell culture procedure. The answer may lie in single-stage procedures that, by using cell combinations, render in vitro expansion redundant. In the last two decades, cocultures of cartilage cells and a variety of (mesenchymal) stem cells have shown promising results as different studies report cartilage regeneration in vitro and in vivo. However, there is considerable debate regarding the mechanisms and cellular interactions that lead to chondrogenesis in these models. This review, which included 52 papers, provides a systematic overview of the data presented in the literature and tries to elucidate the mechanisms that lead to chondrogenesis in stem cell cocultures with cartilage cells. It could serve as a basis for research groups and clinicians aiming at designing and implementing combined cellular technologies for single-stage cartilage repair and treatment or prevention of OA.
Collapse
Affiliation(s)
- Tommy S de Windt
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Jeanine A A Hendriks
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Xing Zhao
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Lucienne A Vonk
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Laura B Creemers
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Wouter J A Dhert
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Mark A Randolph
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Daniel B F Saris
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| |
Collapse
|
23
|
de Windt TS, Hendriks JAA, Zhao X, Vonk LA, Creemers LB, Dhert WJA, Randolph MA, Saris DBF. Concise review: unraveling stem cell cocultures in regenerative medicine: which cell interactions steer cartilage regeneration and how? Stem Cells Transl Med 2014; 3:723-33. [PMID: 24763684 DOI: 10.5966/sctm.2013-0207] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
Cartilage damage and osteoarthritis (OA) impose an important burden on society, leaving both young, active patients and older patients disabled and affecting quality of life. In particular, cartilage injury not only imparts acute loss of function but also predisposes to OA. The increase in knowledge of the consequences of these diseases and the exponential growth in research of regenerative medicine have given rise to different treatment types. Of these, cell-based treatments are increasingly applied because they have the potential to regenerate cartilage, treat symptoms, and ultimately prevent or delay OA. Although these approaches give promising results, they require a costly in vitro cell culture procedure. The answer may lie in single-stage procedures that, by using cell combinations, render in vitro expansion redundant. In the last two decades, cocultures of cartilage cells and a variety of (mesenchymal) stem cells have shown promising results as different studies report cartilage regeneration in vitro and in vivo. However, there is considerable debate regarding the mechanisms and cellular interactions that lead to chondrogenesis in these models. This review, which included 52 papers, provides a systematic overview of the data presented in the literature and tries to elucidate the mechanisms that lead to chondrogenesis in stem cell cocultures with cartilage cells. It could serve as a basis for research groups and clinicians aiming at designing and implementing combined cellular technologies for single-stage cartilage repair and treatment or prevention of OA.
Collapse
Affiliation(s)
- Tommy S de Windt
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Jeanine A A Hendriks
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Xing Zhao
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Lucienne A Vonk
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Laura B Creemers
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Wouter J A Dhert
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Mark A Randolph
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| | - Daniel B F Saris
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands; CellCoTec, Bilthoven, The Netherlands; Laboratory of Musculoskeletal Tissue Engineering, Department of Orthopaedic Surgery, and Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands; MIRA Institute for Biotechnology and Technical Medicine, University Twente, Enschede, The Netherlands
| |
Collapse
|